查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1495950

鼻腔包裝設備市場－2024年至2029年預測

Nasal Packaging Devices Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

鼻腔包裝設備市場預計將從2022年的178,456,000美元成長到2029年的250,677,000美元，複合年成長率為4.97%。

鼻包裝裝置是醫療設備，旨在在各種手術後在鼻腔內提供支撐、控制出血並防止粘連（組織粘在一起）。這些裝置通常在鼻部組織脆弱且容易出血的手術後使用，例如鼻中隔重建、鼻竇和鼻竇手術。

鼻部問題盛行率的上升和意識的提高以及手術數量的增加是鼻部包裝設備市場的主要成長動力。此外，老年人口的迅速增加以及包裝技術的開拓預計將加速市場擴張。

市場促進因素

  • 鼻部疾病發生率增加

隨著慢性鼻竇、鼻中隔偏曲和鼻部外傷等鼻部疾病的盛行率持續上升，對鼻部包裝裝置的需求將會增加，以在手術後或作為治療計劃的一部分來控制這些疾病。

例如，僅在美國，鼻竇每年就影響約 3,000 萬人。據鼻竇和過敏健康中心稱，鼻竇感染造成數十億美元的經濟損失和數百萬工作日的損失。此外，鼻竇每年導致約 7,300 萬天的活動受限。根據梅奧診所的數據，大約 70% 至 80% 的人有鼻中隔明顯偏曲的情況。

  • 外科手術呈上升趨勢

世界範圍內，包括鼻整形術、鼻中隔重建和鼻竇手術在內的鼻部手術數量正在增加。這些手術通常需要鼻包裝裝置來控制出血、促進癒合並達到最佳手術效果。

例如，密西根大學耳鼻喉科每年進行近 500 例鼻腔手術，接待約 1,600 萬名患者。此外，UT 西南耳鼻喉科每年進行約 700 例功能性內視鏡鼻竇手術。

  • 先進封裝技術

技術創新促進了更有效、更適合患者的鼻部包裝設備的開發。這些進步包括生物相容性材料的使用、改進的設計和侵入性較小的插入技術。

鼻腔包裝裝置使用生物相容性材料，如醫用級矽膠、水凝膠和可吸收聚合物，以最大限度地減少組織刺激，降低過敏反應的風險，並促進更好的癒合。 3D 列印技術的進步使得可以根據每位患者的鼻部解剖結構創建個人化的鼻部包裝裝置。這提供了更好的貼合性並改善術後結果。

此外，一些鼻腔包裝裝置具有藥物釋放型功能，可將藥物和治療劑直接釋放到鼻腔中，以促進癒合、減少發炎和預防感染。

  • 老化

在人口老化中，更容易出現與鼻子和鼻竇相關的問題。隨著世界人口持續老化，對鼻腔手術及相關設備的需求將會增加，這很可能會刺激鼻腔包裝設備市場。老年鼻炎患者可能會出現鼻塞或鼻塞、流鼻水過多、鼻子發癢、打噴嚏、鼻道乾燥和結痂等症狀。

例如，根據世界衛生組織的數據，2015年至2050年間，全球60歲及以上老年人的比例將從12%增加到22%。

  • 意識和教育

隨著患者和醫療保健專業人員對適當術後護理益處的認知不斷提高，鼻腔包裝設備市場可能會成長。為此，我們正在做出一些努力。

例如，2021 年 3 月，亨利·福特醫師發起了一項全球計劃，旨在加強全球耳鼻喉科醫生和牙科專業人員之間的跨學科合作，以檢測牙源性鼻竇(ODS)。此外，每年，美國耳鼻喉頭頸外科學會 (AAO-HNS) 都會支持表彰世界鼻竇健康意識日。

2022 年，這項贊助是與美國鼻科學會以及企業合作夥伴美敦力 (Medtronic) 合作實施的。

市場限制因素：

儘管鼻腔包裝設備市場正在經歷成長和開拓，但一些限制和挑戰可能會影響市場的擴張。例如，使用尖端材料和技術開發和製造先進的鼻包裝裝置可能會導致製造成本增加。

這些成本可能會影響患者和醫療保健提供者的定價和可及性。使用一次性鼻腔包裝裝置會產生醫療廢棄物。隨著永續性變得更加重要，開發環保包裝解決方案可能變得必要。

北美地區預計將大幅成長

預計在預測期內，北美將佔據鼻腔包裝設備市場的重要佔有率。

這一佔有率是由於擴大使用鼻腔填塞設備來解決因鼻腔和鼻竇疾病增加而導致的流鼻血患者數量的增加，以及越來越多的參與企業該地區的市場，以下是我們正在做的一些事。例如，根據密西根大學衛生部門的數據，慢性鼻竇影響美國約 3,100 萬人。

主要市場參與企業

  • Anthony Products 是一家專門為包括耳鼻喉科在內的各種醫療領域製造和供應醫療設備、器材與設備的公司。我們有鼻墊片、30秒Psyrocket鼻貼等。
  • Innovia Medical 成立於 1978 年，是一家專注於化妝品、耳鼻喉等各個領域的外科公司。該公司提供 Absorbent® 解剖鼻包用於流鼻血管理。
  • Nipro 是一家日本醫療設備製造商，成立於 1954 年。該公司的 Exadose(TM) 鼻噴劑採用新穎的兩步驟計量劑量方法。獨特的柱塞設計可以精確地將半劑量注射到每個鼻腔中。

新興市場的主要發展

  • 2023年7月，FDA核准Harm Reduction Therapeutics公司開發的RiVive™非鼻噴霧作為鴉片類藥物過量攝取的緊急治療方法。
  • 2022 年 11 月，藥物輸送和活性物質科學解決方案領域的佼佼者 Aptar Pharma 是一家臨床階段生物製藥公司，專門利用取得專利的薄膜冷凍技術平台開發和商業化創新藥物，宣布與 TFF 建立合作夥伴關係。製藥公司此次合作的重點是開發和評估乾粉疫苗遞送方法，該方法將 TFF Pharmaceutical 的薄膜冷凍技術與 Aptar Pharma 專有的鼻單劑量 (UDS) 粉末鼻噴霧系統相結合。
  • 2020 年 12 月，美敦力推出 Novapak鼻竇填塞和支架，這是專為鼻竇手術後使用而設計的一次性可溶解填塞物。它有助於控制出血，防止粘連，為患者的早期康復創造一個濕潤的癒合環境。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行概述

  • 主要發現
  • 分析師觀點

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章鼻包裝設備市場：依產品

  • 介紹
  • 注射
  • 凝膠
  • 噴
  • 敷料

第6章鼻包裝設備市場：依類型

  • 介紹
  • 生物可吸收的
  • 不可吸收

第7章鼻包裝設備市場：依最終用戶分類

  • 介紹
  • 醫院
  • 診所
  • 其他

第8章鼻包裝設備市場：按地區

  • 介紹
  • 北美洲
  • 南美洲
  • 歐洲
  • 中東/非洲
  • 亞太地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 有競爭力的儀表板

第10章 公司簡介

  • Meril Life
  • Anthony Products
  • Medtronic
  • Entsho
  • Innovia Medical
  • Cenefom
  • Nipro
  • Lohmann & Rauscher
  • Medline
簡介目錄
Product Code: KSI061616031

The nasal packaging devices market is expected to grow at a CAGR of 4.97% from US$178.456 million in 2022 to US$250.677 million in 2029.

Nasal packaging devices are medical devices designed to provide support, control bleeding, and prevent adhesions (tissue sticking together) in the nasal cavity after various procedures. These devices are often used following nasal surgeries, such as septoplasty, rhinoplasty, or sinus surgery, where the nasal tissues can be delicate and prone to bleeding.

The rising prevalence of nasal problems coupled with increasing awareness and more surgeries are major growth drivers of the nasal packaging devices market. Moreover, the rapidly growing elderly population along with the technological developments in packaging is further contemplated to accelerate the market expansion.

MARKET DRIVERS:

  • Rising Incidence of Nasal Conditions

As the prevalence of nasal conditions such as chronic sinusitis, deviated septum, and nasal trauma continues to rise, the demand for nasal packaging devices to manage these conditions post-surgery or as part of treatment plans increases.

For instance, sinusitis affects around 30 million persons in the United States alone each year. It has an economic effect of billions of dollars and millions of days of missed work time according to the Sinus & Allergy Wellness Centre. Moreover, sinusitis accounts for roughly 73 million restricted activity days each year. Around 70 to 80 percent of individuals exhibit a noticeable deviation of the nasal septum according to a Mayo Clinic.

  • Growing Number of Surgical Procedures

The number of nasal surgeries, including rhinoplasty, septoplasty, and sinus surgeries, is on the rise globally. These procedures often require nasal packaging devices to control bleeding, promote healing, and ensure optimal surgical outcomes.

For instance, the otolaryngology Department of the University of Michigan Health performs nearly 500 nasal surgical interventions and around 16 million patients visit in a year. Additionally, around 700 functional endoscopic sinus surgery procedures are done at UT Southwestern each year as per the statement of M.D. Professor of Otolaryngology.

  • Advancements in Packaging Technology

Technological innovations have led to the development of more effective and patient-friendly nasal packaging devices. These advancements include the use of biocompatible materials, improved designs, and less invasive insertion techniques.

The use of biocompatible materials, such as medical-grade silicone, hydrogels, and absorbable polymers, in nasal packaging devices minimizes tissue irritation, reduces the risk of allergic reactions, and promotes better healing. Advancements in 3D printing technology allow for the creation of personalized nasal packaging devices tailored to individual patients' nasal anatomy. This promotes a better fit and improved post-operative outcomes.

Additionally, some nasal packaging devices incorporate drug-eluting capabilities, releasing medications or therapeutic agents directly into the nasal cavity to enhance healing, reduce inflammation, and prevent infection.

  • Aging Population

The aging population is more prone to nasal and sinus-related issues. As the global population continues to age, the demand for nasal surgeries and associated devices is likely to increase thereby stimulating the nasal packaging devices market. Individuals experiencing geriatric rhinitis might encounter symptoms such as blocked or congested nasal passages, excessive nasal discharge, itching in the nose, sneezing, as well as dryness or the formation of crusts within the nasal passages.

For instance, the percentage of people aged over 60 years worldwide will increase from 12% to 22% between 2015 and 2050 according to the WHO.

  • Increasing Awareness and Education

As awareness among patients and healthcare professionals about the benefits of proper post-operative care increases, the nasal packaging devices market is likely to grow. Several initiatives are being undertaken in this aim.

For instance, in March 2021, a Henry Ford physician launched a worldwide study effort to increase interdisciplinary collaboration between otolaryngologists and dental professionals throughout the world for detecting odontogenic sinusitis (ODS). Moreover, Annually, the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) endorses the recognition of World Sinus Health Awareness Day.

In 2022, this sponsorship was carried out in partnership with the American Rhinologic Society and in collaboration with the corporate partner Medtronic.

MARKET RESTRAINTS:

The nasal packaging devices market has experienced growth and development however some restraints or challenges can impact its expansion. For example, developing and manufacturing advanced nasal packaging devices with cutting-edge materials and technologies can lead to higher production costs.

These costs can subsequently impact pricing and accessibility for patients and healthcare providers. The use of disposable nasal packaging devices can contribute to medical waste. As sustainability becomes a more significant concern, there may be pressure to develop environmentally friendly packaging solutions.

North America is Expected to Grow Considerably

North America is expected to hold a significant share of the nasal packaging devices market during the forecast period.

The factors attributed to such a share are the growing use of nasal packing devices to treat a rising number of epistaxis patients due to the rising nose and sinus disorders, as well as an increase in the number of market players in the region. For instance, chronic sinusitis affects nearly 31 million people in the US according to the University of Michigan Health.

Major Market Players

  • Anthony Products is a company that specializes in manufacturing and supplying medical devices, instruments, and equipment for a wider range of medical fields including otolaryngology. It deals in nasal drip pads, 30-second rhino rocket nasal packs, and more.
  • Innovia Medical, founded in 1978 is a surgical specialty company in various fields such as aesthetics, ear, nose, and throat, among others. AbsorbENT(R) Anatomical Nasal Packs are offered by the company for epistaxis management. It uses three-dimensional linked open cells that are soft and malleable.
  • Nipro, established in 1954 is a Japanese medical equipment manufacturing company. The Exadose(TM) Nasal Spray offered by the company has a novel two-step quantitative delivery method. The unique plunger design guarantees that half a dosage is administered precisely in each nasal cavity.

Key Market Developments

  • In July 2023, the FDA approved RiVive(TM) Over-the-Counter Nasal Spray developed by Harm Reduction Therapeutics for the emergency treatment of opioid overdose.
  • In November 2022, Aptar Pharma, a prominent player in the field of drug delivery and active material science solutions, has revealed a partnership with TFF Pharmaceuticals, Inc., a biopharmaceutical company in the clinical stage dedicated to the creation and distribution of innovative drug products utilizing its patented Thin Film Freezing technology platform. The collaboration is focused on the development and evaluation of dry powder vaccines administration using TFF Pharmaceutical's Thin Film Freezing technology combined with Aptar Pharma's exclusive intranasal Unidose (UDS) Powder Nasal Spray System.
  • In December 2020, Medtronic launched the Novapak Nasal Sinus Packing and Stent, a disposable and dissolvable packing specifically designed for post-sinus surgery use. It helps control bleeding, prevent adhesions, and create a moist healing environment for rapid patient recovery.

Segmentation:

By Product

  • Injectable
  • Gel
  • Spray
  • Dressings

By Type

  • Bio-Resorbable
  • Non-Absorbable

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • United States
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base, and Forecast Years Timeline
  • 1.8. Key Benefits for the stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings
  • 3.2. Analyst View

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. NASAL PACKAGING DEVICES MARKET, BY PRODUCT

  • 5.1. Introduction
  • 5.2. Injectable
    • 5.2.1. Market Trends and Opportunities
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Gel
    • 5.3.1. Market Trends and Opportunities
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Spray
    • 5.4.1. Market Trends and Opportunities
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Dressings
    • 5.5.1. Market Trends and Opportunities
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness

6. NASAL PACKAGING DEVICES MARKET, BY TYPE

  • 6.1. Introduction
  • 6.2. Bio-resorbable
    • 6.2.1. Market Trends and Opportunities
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Non-absorbable
    • 6.3.1. Market Trends and Opportunities
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness

7. NASAL PACKAGING DEVICES MARKET, BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
    • 7.2.1. Market Trends and Opportunities
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Clinics
    • 7.3.1. Market Trends and Opportunities
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness
  • 7.4. Others
    • 7.4.1. Market Trends and Opportunities
    • 7.4.2. Growth Prospects
    • 7.4.3. Geographic Lucrativeness

8. NASAL PACKAGING DEVICES MARKET, BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product
    • 8.2.2. By Type
    • 8.2.3. By End-user
    • 8.2.4. By Country
      • 8.2.4.1. United States
        • 8.2.4.1.1. Market Trends and Opportunities
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Trends and Opportunities
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Trends and Opportunities
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product
    • 8.3.2. By Type
    • 8.3.3. By End-user
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Trends and Opportunities
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Trends and Opportunities
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Trends and Opportunities
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product
    • 8.4.2. By Type
    • 8.4.3. By End-user
    • 8.4.4. By Country
      • 8.4.4.1. United Kingdom
        • 8.4.4.1.1. Market Trends and Opportunities
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. Germany
        • 8.4.4.2.1. Market Trends and Opportunities
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. France
        • 8.4.4.3.1. Market Trends and Opportunities
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Spain
        • 8.4.4.4.1. Market Trends and Opportunities
        • 8.4.4.4.2. Growth Prospects
      • 8.4.4.5. Others
        • 8.4.4.5.1. Market Trends and Opportunities
        • 8.4.4.5.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product
    • 8.5.2. By Type
    • 8.5.3. By End-user
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Trends and Opportunities
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Trends and Opportunities
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Israel
        • 8.5.4.3.1. Market Trends and Opportunities
        • 8.5.4.3.2. Growth Prospects
      • 8.5.4.4. Others
        • 8.5.4.4.1. Market Trends and Opportunities
        • 8.5.4.4.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product
    • 8.6.2. By Type
    • 8.6.3. By End-user
    • 8.6.4. By Country
      • 8.6.4.1. Japan
        • 8.6.4.1.1. Market Trends and Opportunities
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. China
        • 8.6.4.2.1. Market Trends and Opportunities
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. India
        • 8.6.4.3.1. Market Trends and Opportunities
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Trends and Opportunities
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Indonesia
        • 8.6.4.5.1. Market Trends and Opportunities
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Trends and Opportunities
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Others
        • 8.6.4.7.1. Market Trends and Opportunities
        • 8.6.4.7.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Meril Life
  • 10.2. Anthony Products
  • 10.3. Medtronic
  • 10.4. Entsho
  • 10.5. Innovia Medical
  • 10.6. Cenefom
  • 10.7. Nipro
  • 10.8. Lohmann & Rauscher
  • 10.9. Medline